Chembio Diagnostics, Inc. / Fundamentals
Income statement
- Net revenue
€41.72M - Cost of goods sold
€33.30M - Gross profit
€8.42M - SG&A expenses
€20.95M - R&D expenses
€6.10M - EBITDA
-€15.24M - D&A
€2.30M - EBIT
-€20.40M - Interest expenses
€2.20M - EBT
-€20.07M - Tax expenses
€1.44M - Net income
-€20.10M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€3.20M - Changes in working capital
€1.76M - Operating cash flow
-€10.96M - Capex
€1.25M - Other investing cash flow
€0.00 - Net investing cash flow
-€1.25M - Total cash dividends paid
€0.00 - Issuance of common stock
€335.06K - Debt repayment
€0.00 - Other financing cash flow
€2.91M - Net financing cash flow
€2.91M - Foreign exchange effects
€158.82K - Net change in cash
-€9.14M - Cash at end of period
€15.69M - Free cash flow
-€9.70M
Balance sheet
- Cash and cash equivalents
€15.69M - Cash and short-term investments
€15.69M - Total receivables
€16.16M - Inventory
€6.66M - Other current assets
€3.31M - Total current assets
€41.82M - Property, plant & equipment
€11.85M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€375.31K - Total non-current assets
€12.22M - Total assets
€54.04M - Accounts payable
€2.89M - Short-term debt
€16.89M - Other current liabilities
€14.14M - Total current liabilities
€33.92M - Long-term debt
€4.76M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€4.76M - Total liabilities
€38.68M - Common stock
€317.30K - Retained earnings
-€133.17M - Other equity
-€291.09K - Total equity
€15.36M - Total liabilities and shareholders' equity
€54.04M
Company information
- Market capitalization
€14.25M - Employees
188 - Enterprise Value
€23.61M
Company ratios
- Gross margin
-
20.2% Much better than peer group: -40,391.1% - EBITDA margin
-
-36.5% Much better than peer group: -1,398.2% - EBIT margin
-
-48.9% Much better than peer group: -1,351.0% - EBT margin
-
-48.1% Much better than peer group: -1,845.2% - Net margin
-
-48.2% Much better than peer group: -1,855.5% - ROE
-
-130.9% Much better than peer group: -1,678.8% - ROA
-
-37.2% Much better than peer group: -26,173.8% - Asset turnover
-
77.2% Much better than peer group: 21.3% - FCF margin
-
-29.3% Much better than peer group: -1,946.4% - FCF yield
-85.7% - Efficiency ratio
136.5% - Net sales per employee
-
€221.91K - Net income per employee
-
-€106.92K